3 Biotech Stocks That Jumped Last Week
If you're looking for stocks that can rocket higher overnight, the biotech space is a good place to start. Hardly a week goes by without big gains from at least a few members of this industry, which produces about one new publicly traded company per week.
If you haven't been able to stay on top of them all, we've got you covered. Read on to see why investors pushed these three biotech stocks a lot higher last week.
Data source: Yahoo! Finance.
This company's lead drug, sotagliflozin, earned approval in the EU a couple of years ago, but the FDA raised concerns that kept it from reaching U.S. pharmacy shelves. Lexicon Pharmaceuticals stock jumped last week when the company told investors the FDA is willing to review a new application supported by results from the Soloist and Scored trials for a much larger indication than type 1 diabetes, as originally planned.
Source Fool.com
